These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 18422916

  • 1. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.
    Di Fonzo EM, Martini P, Mazzatenta C, Lotti L, Alvino S.
    Mycoses; 2008 Nov; 51(6):532-5. PubMed ID: 18422916
    [Abstract] [Full Text] [Related]

  • 2. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.
    Rigopoulos D, Gregoriou S, Kontochristopoulos G, Ifantides A, Katsambas A.
    Mycoses; 2007 May; 50(3):193-5. PubMed ID: 17472615
    [Abstract] [Full Text] [Related]

  • 3. Can pityriasis versicolor be treated with 2% ketoconazole foam?
    Cantrell WC, Elewksi BE.
    J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
    [Abstract] [Full Text] [Related]

  • 4. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Yazdanpanah MJ, Azizi H, Suizi B.
    Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
    [Abstract] [Full Text] [Related]

  • 5. Fluconazole versus ketoconazole in the treatment of tinea versicolor.
    Farschian M, Yaghoobi R, Samadi K.
    J Dermatolog Treat; 2002 Jun; 13(2):73-6. PubMed ID: 12060505
    [Abstract] [Full Text] [Related]

  • 6. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A, Saúl A.
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [Abstract] [Full Text] [Related]

  • 7. Ketoconazole--an effective treatment for disseminated pityriasis versicolor.
    Schewach-Millet M, Kahana M, Levy A, Yaron-Schiffer O, Sommer B, Shalish L.
    Isr J Med Sci; 1984 May; 20(5):417-9. PubMed ID: 6088425
    [Abstract] [Full Text] [Related]

  • 8. [A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor].
    Rekacewicz I, Guillaume JC, Benkhraba F, Archimbaud A, Baspeyras M, Boitier F, Bussière M, Coin A, Di Crezenzo MC, Duval J.
    Ann Dermatol Venereol; 1990 May; 117(10):709-11. PubMed ID: 2073061
    [Abstract] [Full Text] [Related]

  • 9. Roles of adapalene in the treatment of pityriasis versicolor.
    Shi TW, Ren XK, Yu HX, Tang YB.
    Dermatology; 2012 May; 224(2):184-8. PubMed ID: 22572567
    [Abstract] [Full Text] [Related]

  • 10. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.
    Gobbato AA, Babadópulos T, Gobbato CA, Ilha Jde O, Gagliano-Jucá T, De Nucci G.
    Expert Opin Investig Drugs; 2015 May; 24(11):1399-407. PubMed ID: 26419668
    [Abstract] [Full Text] [Related]

  • 11. [Itraconazole in the treatment of pityriasis versicolor: comparison between 5 and 7 days of treatment].
    Cucé LC, Belda Júnior W, Ribeiro EB.
    Rev Inst Med Trop Sao Paulo; 1990 May; 32(3):181-4. PubMed ID: 1966916
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid.
    Quadri G, Cavallero W, Milani M.
    J Cosmet Dermatol; 2005 Jan; 4(1):23-6. PubMed ID: 17134417
    [Abstract] [Full Text] [Related]

  • 13. Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole.
    Rausch LJ, Jacobs PH.
    Cutis; 1984 Nov; 34(5):470-1. PubMed ID: 6094116
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor.
    Shi TW, Zhang JA, Tang YB, Yu HX, Li ZG, Yu JB.
    J Dermatolog Treat; 2015 Apr; 26(2):143-6. PubMed ID: 24802530
    [Abstract] [Full Text] [Related]

  • 15. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
    Elewski BE, Abramovits W, Kempers S, Schlessinger J, Rosen T, Gupta AK, Abraham S, Rowell R.
    J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
    [Abstract] [Full Text] [Related]

  • 16. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
    Koc E, Arca E, Kose O, Akar A.
    J Dermatolog Treat; 2009 Oct; 20(1):4-9. PubMed ID: 18677657
    [Abstract] [Full Text] [Related]

  • 17. [Oxiconazole cream versus ketoconazole cream. A prospective, randomized, double-blind, multicenter study in the treatment of inguinocrural dermatophytoses].
    Kalis B, Grosshans E, Binet O, Garrel JB, Grossetête G, Jeanpierre G, Privat Y, Sonneck JM, Souteyrand P.
    Ann Dermatol Venereol; 1996 Oct; 123(8):447-52. PubMed ID: 9033712
    [Abstract] [Full Text] [Related]

  • 18. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D, Gurbuz O, Akin O.
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of oral and topical ketoconazole therapy in pityriasis versicolor.
    Nagpal VB, Jain VK, Aggarwal K.
    Indian J Dermatol Venereol Leprol; 2003 Mar; 69(4):287-8. PubMed ID: 17642914
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial.
    Elewski B, Ling MR, Phillips TJ.
    J Drugs Dermatol; 2006 Mar; 5(7):646-50. PubMed ID: 16865870
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.